Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Expert Opin Drug Discov. 2019 Jun 11;14(9):933–945. doi: 10.1080/17460441.2019.1626822

Figure 1.

Figure 1.

Typical drug discovery pipeline. X-ray crystallography contributes to this process mainly by providing initial crystal structure templates for VLS and co-crystal structures during hit-to-lead optimization (outlined in blue). Structural information may also help with target validation and selection of the most promising drug candidates for animal and clinical trials.